NEUPHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Key data

Status

Active

KRS number

REGON

NIP/VAT code

VAT registration date

01/11/2018

VAT status

Active

Bankruptcy proceedings

No proceedings

NEUPHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Contacts

Registered address

See on map

Website

Not calculated

Highest reliabilityLowest reliability

Reliability

A - Highest

B - High

C - Average

D - Low

E - Lowest

Prescore cannot be calculated due to significantly decreased turnover, expert evaluation needed.

Incorporation date

21/11/2017

Share capital

200,000.00 PLN

Primary activity

Security activities, not elsewhere classified (74.99.Z - PKD 2025)

Representatives

Representatives rights

W PRZYPADKU ZARZĄDU JEDNOOSOBOWEGO OŚWIADCZENIA W IMIENIU SPÓŁKI SKŁADA CZŁONEK ZARZĄDU. W PRZYPADKU ZARZĄDU SKŁADAJĄCEGO SIĘ Z DWÓCH LUB WIĘKSZEJ LICZBY OSÓB DO SKŁADANIA OŚWIADCZEŃ W IMIENIU SPÓŁKI JEST WYMAGANE WSPÓŁDZIAŁANIE DWÓCH CZŁONKÓW ZARZĄDU ALBO JEDNEGO CZŁONKA ZARZĄDU ŁĄCZNIE Z PROKURENTEM.

Representatives

Chairman of the management boardS***** A****

Business linkages

Price: zł63.00
Premium users: 1.00 credit

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

People

Representatives

Person	Title
S*** A**	Chairman of the management board

Persons with Significant Control

This information is available in our reports and to subscription users.

Financial ratios

Net Profit (zł)

1,528,559

Net Profit (zł)

1,528,559

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

Indicator
Turnover (zł)
Profit before tax (zł)
Net Profit (zł)
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business.
Liquidity ratio liquidityRatio
Net profitability (%) This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales.
Equity (zł)
Current liabilities (zł)
Non current liabilities (zł)
Non-current Assets (zł)

2022
0
-
-13,783
-
-
-
-10,471
0
0
3,000

2023
0
-187,316
-187,316
-
0.21
-
-198,414
273,990
0
19,000

2024
19,352,162
1,861,743
1,528,559
0.10
1.36
7.90
1,330,144
5,399,197
0
-

2024
19,352,162
1,861,743
1,528,559
0.10
1.36
7.90
1,330,144
5,399,197
0
-

Turnover (zł)

2024

Turnover (zł)

19,352,162 zł- *

Profit before tax (zł)

1,861,743 zł1,094 % *

Net Profit (zł)

1,528,559 zł916 % *

Working capital requirement (%)

0.10 - *

Liquidity ratio

1.36 547.62 % *

Net profitability (%)

7.90 %- *

Equity (zł)

1,330,144 zł770 % *

Current liabilities (zł)

5,399,197 zł1,871 % *

Non current liabilities (zł)

0 zł- *

Non-current Assets (zł)

*over the last year starting selected period

Credit history

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

Credit report

Price: 1.00 credit

Unpaid debts

Creditor/Data source	Debt amount	Debt date	Debt type
-	-	-	-

Debt payment history

Creditor/Data source	Debt amount	Debt date	Payment date	Debt type
-	-	-	-	-

Documents

NEUPHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Documents

Date	Description
02/09/2025	OD 01.01.2024 DO 31.12.2024
18/03/2025	OD 01.01.2021 DO 31.12.2021
18/03/2025	OD 01.01.2023 DO 31.12.2023
03/09/2024	OD 01.01.2022 DO 31.12.2022
24/01/2022	OD 01.01.2020 DO 31.12.2020